Literature DB >> 8682294

Shared role of the pRB-related p130 and p107 proteins in limb development.

D Cobrinik1, M H Lee, G Hannon, G Mulligan, R T Bronson, N Dyson, E Harlow, D Beach, R A Weinberg, T Jacks.   

Abstract

The p130 protein shares extensive sequence similarity with pRB, the product of the retinoblastoma gene, and is a major E2F-associated protein in quiescent cells. To investigate its biological function, we have mutated p130 via gene targeting in the mouse. Homozygous mutation of p130 had little discernible effect on development or on the growth of mouse embryo fibroblasts in culture. Much of the E2F activity that normally associates with p130 in serum-starved mouse embryo fibroblasts associated instead with the highly related p107 protein. To determine whether p130 and p107 have overlapping biological roles, we produced mice having simultaneous inactivation of the p130 and p107 genes. Such mice exhibited deregulated chondrocyte growth, defective endochondral bone development, shortened limbs, and neonatal lethality. These findings indicate that p130 and p107 play an important role in limb development through their abilities to control chondrocyte proliferation. Thus, in certain settings p107 and p130 perform growth-regulatory functions that are not fulfilled by pRB.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8682294     DOI: 10.1101/gad.10.13.1633

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  154 in total

1.  E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis.

Authors:  H Müller; A P Bracken; R Vernell; M C Moroni; F Christians; E Grassilli; E Prosperini; E Vigo; J D Oliner; K Helin
Journal:  Genes Dev       Date:  2001-02-01       Impact factor: 11.361

2.  Targeted disruption of the three Rb-related genes leads to loss of G(1) control and immortalization.

Authors:  J Sage; G J Mulligan; L D Attardi; A Miller; S Chen; B Williams; E Theodorou; T Jacks
Journal:  Genes Dev       Date:  2000-12-01       Impact factor: 11.361

3.  Ablation of the retinoblastoma gene family deregulates G(1) control causing immortalization and increased cell turnover under growth-restricting conditions.

Authors:  J H Dannenberg; A van Rossum; L Schuijff; H te Riele
Journal:  Genes Dev       Date:  2000-12-01       Impact factor: 11.361

4.  Timing of cyclin E gene expression depends on the regulated association of a bipartite repressor element with a novel E2F complex.

Authors:  L Le Cam; J Polanowska; E Fabbrizio; M Olivier; A Philips; E Ng Eaton; M Classon; Y Geng; C Sardet
Journal:  EMBO J       Date:  1999-04-01       Impact factor: 11.598

5.  E2F mediates cell cycle-dependent transcriptional repression in vivo by recruitment of an HDAC1/mSin3B corepressor complex.

Authors:  Joseph B Rayman; Yasuhiko Takahashi; Vahan B Indjeian; Jan-Hermen Dannenberg; Steven Catchpole; Roger J Watson; Hein te Riele; Brian David Dynlacht
Journal:  Genes Dev       Date:  2002-04-15       Impact factor: 11.361

Review 6.  Integration of the pRB and p53 cell cycle control pathways.

Authors:  C L Stewart; A M Soria; P A Hamel
Journal:  J Neurooncol       Date:  2001-02       Impact factor: 4.130

7.  Opposing roles of pRB and p107 in adipocyte differentiation.

Authors:  M Classon; B K Kennedy; R Mulloy; E Harlow
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

8.  Combinatorial roles for pRB, p107, and p130 in E2F-mediated cell cycle control.

Authors:  M Classon; S Salama; C Gorka; R Mulloy; P Braun; E Harlow
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

9.  RNA polymerase III transcription factor IIIB is a target for repression by pocket proteins p107 and p130.

Authors:  J E Sutcliffe; C A Cairns; A McLees; S J Allison; K Tosh; R J White
Journal:  Mol Cell Biol       Date:  1999-06       Impact factor: 4.272

10.  The role of E2F4 in adipogenesis is independent of its cell cycle regulatory activity.

Authors:  Rebecca L Landsberg; Julia E Sero; Paul S Danielian; Tina L Yuan; Eunice Y Lee; Jacqueline A Lees
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-25       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.